The Patent Finder

Nivagen Pharmaceuticals, Inc.

11 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

0
Ending by 2030
Sep 2040
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due May 14, 2027
    The maintenance fee for Ready-to-use potassium phosphates in sodium chloride solutions (US 11,813,291) comes due May 14, 2027. Unpaid by Nov 15, 2027, it lapses early.
  • 1 fee due Jul 23, 2027
    The maintenance fee for Lyophilized compositions of phenobarbital sodium salt (US 11,878,076) comes due Jul 23, 2027. Unpaid by Jan 24, 2028, it lapses early.
  • 1 fee due Sep 12, 2027
    The maintenance fee for Ready-to-use potassium phosphates in sodium chloride solutions (US 11,925,661) comes due Sep 12, 2027. Unpaid by Mar 13, 2028, it lapses early.
  • 1 fee due Oct 16, 2027
    The maintenance fee for Chlorthalidone compositions and methods (US 11,957,658) comes due Oct 16, 2027. Unpaid by Apr 17, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,406,598Lyophilized compositions of phenobarbital sodium salt
In force
 · USPTO record
In forceUSPTO record
US 11,878,076Lyophilized compositions of phenobarbital sodium salt
In force
 · USPTO record
In forceUSPTO record
US 11,957,658Chlorthalidone compositions and methods
In force
 · USPTO record
In forceUSPTO record
US 11,925,661Ready-to-use potassium phosphates in sodium chloride solutions
In force
 · USPTO record
In forceUSPTO record
US 11,672,823Calcium Gluconate Formulation Without Calcium Saccharate
In force
 · High confidence
In forceHigh confidence
US 11,813,291Ready-to-use potassium phosphates in sodium chloride solutions
In force
 · USPTO record
In forceUSPTO record
US 12,102,624Pantoprazole compositions and methods
In force
 · USPTO record
In forceUSPTO record
US 12,667,545Lyophilized Compositions of Phenobarbital Sodium Salt
In force
 · Low confidence
In forceLow confidence
US 12,343,427Stable intravenous diltiazem hydrochloride formulation and use thereof
In force
 · USPTO record
In forceUSPTO record
US 12,115,187Ready-To-Use Sodium Phosphates Injection
In force
 · High confidence
In forceHigh confidence
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending · 1 abandoned · 3 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited